Tibial Nerve Neuromodulator Regulates Active Bladders
|
By HospiMedica International staff writers Posted on 12 Sep 2018 |
|
Image: A small implantable neurostimulator helps control overactive bladders (Photo courtesy of BlueWind Medical).
A safe, minimally invasive system offers durable and significant improvements for over active bladder (OAB) patients.
The BlueWind Medical (Herzliya, Israel) Renova iStim is an implantable, miniature, wireless platform for percutaneous neuromodulation (PTNM) of the tibial nerve, which is located near the ankle. The gentle electrical pulse is thought to indirectly activate the central nervous system, helping alleviate OAB symptoms such as urinary frequency (UF) and urinary urge incontinence (UUI) episodes. The device, which is powered wirelessly by an external control unit for just 30 minutes, can be used while performing daily tasks without interruption.
A prospective study conducted in four clinical centers in the United Kingdom and the Netherlands, and results of a six-month follow-up that included 20 of the 36 pilot study patients, showed a sustained high responder rate, comparable with response rates typical of sacral nerve stimulation (SNS). Three years after implantation of the Renova iStim device, 75% of the study patients experienced at least a 50% long-term reduction in OAB symptoms, and durable, long-term UUI relief. No severe adverse events were reported throughout the follow-up study.
“The 36-month study results confirm that the Renova iStim system provides robust and effective long-term performance that could help millions of patients in the management of OAB,” said Efi Cohen Arazi, CEO of RainbowMD (Herzeliya Pituach, Israel), and chairman of the board of BlueWind Medical. “We believe BlueWind has highly differentiated wireless neuromodulation, and this data provides strong evidence of the potential for this technology in OAB and other indications.”
OAB has traditionally been treated by both SNS and tibial nerve stimulation. But while SNS requires a complex implantation procedure of a large device and extension leads, tibial stimulation is less invasive, but is usually administered only at a physician’s clinic, an inconvenience that reduces the frequency of treatment.
Related Links:
BlueWind Medical
RainbowMD
The BlueWind Medical (Herzliya, Israel) Renova iStim is an implantable, miniature, wireless platform for percutaneous neuromodulation (PTNM) of the tibial nerve, which is located near the ankle. The gentle electrical pulse is thought to indirectly activate the central nervous system, helping alleviate OAB symptoms such as urinary frequency (UF) and urinary urge incontinence (UUI) episodes. The device, which is powered wirelessly by an external control unit for just 30 minutes, can be used while performing daily tasks without interruption.
A prospective study conducted in four clinical centers in the United Kingdom and the Netherlands, and results of a six-month follow-up that included 20 of the 36 pilot study patients, showed a sustained high responder rate, comparable with response rates typical of sacral nerve stimulation (SNS). Three years after implantation of the Renova iStim device, 75% of the study patients experienced at least a 50% long-term reduction in OAB symptoms, and durable, long-term UUI relief. No severe adverse events were reported throughout the follow-up study.
“The 36-month study results confirm that the Renova iStim system provides robust and effective long-term performance that could help millions of patients in the management of OAB,” said Efi Cohen Arazi, CEO of RainbowMD (Herzeliya Pituach, Israel), and chairman of the board of BlueWind Medical. “We believe BlueWind has highly differentiated wireless neuromodulation, and this data provides strong evidence of the potential for this technology in OAB and other indications.”
OAB has traditionally been treated by both SNS and tibial nerve stimulation. But while SNS requires a complex implantation procedure of a large device and extension leads, tibial stimulation is less invasive, but is usually administered only at a physician’s clinic, an inconvenience that reduces the frequency of treatment.
Related Links:
BlueWind Medical
RainbowMD
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Surgical System
Stealth AXiS
New
Medical Examination & Procedure Light
Vega 80
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
